Skip to content
WeighLab

Kova vs Medro

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Kova

Provider comparison

Shoppers willing to commit to a longer plan to bring compounded semaglutide down toward $129 a month, with an app that tracks protein and side effects.

Semaglutide / month
$299/moMonth to month, compounded
Tirzepatide / month
$399/moMonth to month, compounded
Index 73/100 · Grade CChecked October 2026

Medro

Provider comparison

Shoppers who want a published month-to-month price, no membership fee and 50-state coverage.

Semaglutide / month
$199/moMonthly plan, compounded; first month $99
Tirzepatide / month
$299/moMonthly plan, compounded; first month $199
Index 72/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Kova has the higher Cost-Efficiency Index: 73/100 versus 72/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Kova

Medro

Semaglutide / month
Kova: $299/moMonth to month, compounded
Medro: $199/moMonthly plan, compounded; first month $99
Tirzepatide / month
Kova: $399/moMonth to month, compounded
Medro: $299/moMonthly plan, compounded; first month $199
Semaglutide / year (modeled)
Kova: $3,588
Medro: $2,388
Tirzepatide / year (modeled)
Kova: $4,788
Medro: $3,588
State availability
Kova: All 50 states
Medro: All 50 states
Oral / sublingual option listed
Kova: Not listed
Medro: Not listed
Brand-name access listed
Kova: Not confirmed
Medro: Not confirmed
Provider facts checked
Kova: October 2026
Medro: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Kova

Shoppers willing to commit to a longer plan to bring compounded semaglutide down toward $129 a month, with an app that tracks protein and side effects.

Reasons to consider it

  • Semaglutide drops from $299 a month to $179, $149 and $129 on 3-, 6- and 12-month plans, all listed before you start
  • You aren't charged unless a clinician approves treatment
  • Names its prescribers, led by Dr. Laurie Mercier, and five compounding pharmacies, including Strive and Southend

What to weigh up

  • Month to month is the dearest way to buy: $299 for semaglutide and $399 for tirzepatide after the first month
  • The $129 to $179 semaglutide rates require a 3-, 6- or 12-month commitment
  • Lab work isn't included; if your clinician orders it, you pay for it separately

Medro

Shoppers who want a published month-to-month price, no membership fee and 50-state coverage.

Reasons to consider it

  • Month-to-month prices for both drugs ($199 semaglutide, $299 tirzepatide) are shown before you start the intake
  • LegitScript-certified (seal #50716646, checkable on LegitScript's own site) and available in all 50 states
  • Named clinical partner (Arora Health & Aesthetics, LLC — Dr. Sean Arora, NPI 1841729449, Seattle, WA) and named compounding pharmacy (The Pharmacy Hub, Miami, FL) — both real, both verifiable, though neither is surfaced in the site's marketing copy

What to weigh up

  • The 'flat $99' and '$199' figures in its ads are first-plan prices after an auto-applied $99 code; plans renew at the regular $199 and $299
  • No mg dose is listed next to any price, and the fine print says final pricing can vary by dose and supply length
  • The named clinical partner and pharmacy only appear on legal/FAQ pages, not on the pricing or marketing pages a typical shopper would read

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

KovaMedro
Normalized Cost/Month
Kova:
46/100
Medro:
64/100
Price Transparency
Kova:
92/100
Medro:
92/100
Nationwide Access
Kova:
86/100
Medro:
86/100
Formulation Options
Kova:
66/100
Medro:
66/100
Clinical Oversight
Kova:
76/100
Medro:
63/100
Contract Flexibility
Kova:
77/100
Medro:
53/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.